Research map: Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT)

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2008 · 17695 citations · Cited by this paper
  2. Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · 2026 · Related
  3. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours · Holger Moch · 2022 · 884 citations · Cited by this paper
  4. The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · 2026 · Related
  5. A global federated real-world data and analytics platform for research · Matvey B. Palchuk · 2023 · 829 citations · Cited by this paper
  6. Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · 2026 · Related
  7. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · T. Powles · 2024 · 357 citations · Cited by this paper
  8. Exploration of the Challenges in the Management of Prostate Cancer in East Africa · 2025 · Related
  9. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival · Shaan Dudani · 2021 · 319 citations · Cited by this paper
  10. Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study · 2026 · Related
  11. Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates · Chung‐Han Lee · 2022 · 207 citations · Cited by this paper
  12. Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · 2026 · Related
  13. Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial · Laurence K. Albiges · 2023 · 159 citations · Cited by this paper
  14. Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · 2026 · Related
  15. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study · Sumanta K. Pal · 2021 · 143 citations · Cited by this paper
  16. A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer · 2025 · Related
  17. Age-associated differences in the cancer molecular landscape · Kasit Chatsirisupachai · 2022 · 79 citations · Cited by this paper
  18. Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules · 2025 · Related
  19. Pan-cancer analysis reveals molecular patterns associated with age · Yajas Shah · 2021 · 76 citations · Cited by this paper
  20. Why Has Prostate Cancer Research Lagged Behind? Advocacy, Biology, and the Road Ahead · 2026 · Related
  21. Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds · Panagiotis Zoumpourlis · 2020 · 60 citations · Cited by this paper
  22. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma · Pedro Coelho Barata · 2024 · 41 citations · Cited by this paper
  23. Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database · Zhouning Liao · 2022 · 14 citations · Cited by this paper
  24. Young Patients With Colorectal Cancer Have Higher Early Mortality but Better Long-Term Survival · Shuyuan Wang · 2022 · 14 citations · Cited by this paper
  25. 53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database · Fucai Tang · 2021 · 9 citations · Cited by this paper
  26. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors · Zixuan Xue · 2024 · 9 citations · Cited by this paper
  27. STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma · Sumanta Kumar Pal · 2025 · 6 citations · Cited by this paper
  28. Clinicopathological Features and Prognostic Factors of Renal Cell Carcinoma in Young Patients Under 45 Years: A Single-Center Retrospective Study · Yu Gao · 2025 · 3 citations · Cited by this paper
  29. The Impact of Young Age on Breast Cancer Prognosis: A Systematic Review and Meta-Analysis · Yongxin Li · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)